Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 660.05
-4.40 (-0.66%)
Feb 16, 2026, 1:15 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 33.7 billion as of February 13, 2026. Its market cap has decreased by -53.37% in one year.
Market Cap
33.70B
Enterprise Value
35.03B
Revenue
8.11B
Ranking
n/a
PE Ratio
176.25
Stock Price
660.05
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 33.70B, an increase of 4,533.31%. That is a compound annual growth rate of 106.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 33.70B | -12.45% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 79.05B |
| Akums Drugs and Pharmaceuticals | 69.10B |
| Aarti Pharmalabs | 64.29B |
| Sun Pharma Advanced Research Company | 42.87B |
| Innova Captab | 38.85B |
| RPG Life Sciences | 32.66B |
| Solara Active Pharma Sciences | 24.07B |
| Indoco Remedies | 18.68B |